FDA Clearance Tracker · K250666
Alegria Flash CTD Screen
Last checked: Nov 19, 2026Latest source record: Oct 22, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Oct 22, 2025
Substantially Equivalent
Time to decision
231 days
Received Mar 5, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250666
- Device name
- Alegria Flash CTD Screen
- Applicant
- Zeus Scientific
- Applicant location
- Branchburg, NJ
- Received
- Mar 5, 2025
- Decided
- Oct 22, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.5100
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LLL. The earliest in FDA's data is K810592, decided Oct 23, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250666
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Zeus Scientific
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261466 · Decided Aug 21, 2026 · 109 days after receipt
Device type: Test System, Antineutrophil Cytoplasmic Antibodies (Anca) (MOB) · Laboratory Medicine & Pathology
K250814 · Decided May 8, 2026 · 417 days after receipt
Device type: Anti-Ss-A 52 Autoantibodies (OBE) · Laboratory Medicine & Pathology
- Alegria Flash ENA Screen510(k)
K250408 · Decided Sep 19, 2025 · 218 days after receipt
Device type: Extractable Antinuclear Antibody, Antigen And Control (LLL) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.